Obsidian Therapeutics to Merge with Galera and Raise $350 Million to Advance TIL Cell Therapy
Galera and Obsidian merge to form OBX, advancing TIL cancer therapy for melanoma & lung cancer, backed by $350M funding.
NOTRELOAD AI
CarMax Swings to Q4 Loss as Price Cuts Squeeze Margins — Shares Drop
CarMax posted a Q4 loss due to goodwill charges and weak used-car sales. Revenue slipped, shares fell 13%, cost-cut outlook.
Avanos Medical to Be Acquired by American Industrial Partners for $1.27 Billion
Avanos Medical is being bought by AIP for $1.27B in cash. Shareholders get $25 per share, a big premium. Company goes private in 2026.
Geopolitical Tensions & Hot Dealmaking Power Citigroup’s Best Quarter in a Decade
Citi beat forecasts with strong Q1: higher profits, record revenue, boosted trading, big shareholder returns, stock rose.
Travere Wins Full FDA Approval for FILSPARI – First-Ever Treatment for Rare Kidney Disease FSGS
FDA approved FILSPARI for FSGS kidney disease, showing it lowers protein in urine and slows damage. It offers a new treatment option for patients with few choices.
Novo Nordisk Teams Up with OpenAI: AI Supercharges the Fight Against Obesity
Novo Nordisk teams with OpenAI to use AI for faster drug discovery, production and sales, aiming to catch rivals like Eli Lilly.